Gerd

Gastroesophageal reflux disease affects 1 in 5 people in the United States.; although common, the disease is often unrecognized and misunderstood, the International Foundation for Gastrointestinal Disorders reported.

In this edition, achalasia is associated with higher esophageal cancer risk; FDA rejects bulevirtide for hepatitis D and liver disease; real-world data on colonoscopy prep and more.

Infants exposed to acid suppressant medications did not experience an increased risk for allergen sensitization in early childhood, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The AGA has issued a clinical practice update on de-prescribing proton pump inhibitors, according to an article in Gastroenterology.

LAS VEGAS – Gastroenterologist and dietitian-led lifestyle intervention programs reduced weight and use of acid suppression therapy among patients with GERD, according to a presenter at ACG Annual Scientific Meeting.

Gastroprotective and promotility agents do not appear to prevent clinically apparent systemic sclerosis-associated interstitial lung disease, according to results of a large retrospective cohort study.

The prevalence of infant GERD was highest in the first 3 months of life and decreased with age, according to a study at Digestive Disease Week.

Healio Gastroenterology presents the following reports on the most recent research on the esophagus and GERD.

Healio Gastroenterology presents the following reports on the most recent research on the esophagus and GERD.

Healio Gastroenterology presents the following reports on the most recent research on the esophagus and GERD.